Source-grounded facts extracted from AleAnna, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
AleAnna, Inc. reported first quarter of 2026 results: revenue $8.9 million, net income $3.4 million.
“and future strategic initiatives. Financial and Operational Update Following production ramp-up and stabilization at the Longanesi field during 2025, the Company recognized $8.9 million of revenue during the first quarter of 2026 from sales of its share of production from the Longanesi field. During the first quarter, AleAnna generated net income of $3.4 million”
AleAnna, Inc.: SurvivingPubCo ceased to be a shell company upon the closing of the business combination (effective 2024-12-13).
“As a result of the Business Combination, Surviving PubCo ceased to be a shell company upon the Closing.”
AleAnna, Inc.: The Board approved and adopted a new code of business conduct and ethics (effective 2024-12-13).
“On December 13, 2024, the Board approved and adopted a new code of business conduct and ethics that applies to all of its directors, executive officers and other employees, which is available on Surviving PubCo’s website, www.aleannainc.com, under “Governance.””
AleAnna, Inc. underwent a change of control involving AleAnna Energy, LLC for 65,098,476 shares of a combination of (i) 39,104,076 shares of Surviving PubCo Class A Common Stock and (ii) 25,994,400 shares of Surviving PubCo Class C Common (closed 2024-12-13).
“the surviving company and a wholly-owned subsidiary of HoldCo. The aggregate merger consideration issued to the Company Members immediately prior to the Closing was equal to 65,098,476 shares of a combination of (i) 39,104,076 shares of Surviving PubCo Class A Common Stock and (ii) 25,994,400 shares of Surviving PubCo Class C Common Stock (with one Class C”
AleAnna, Inc.: Amended Articles to extend deadline for initial business combination to June 17, 2025 and to delete the $5,000,001 NTA requirement limitation (effective 2024-03-15).
“At the Meeting, the Company’s shareholders approved a proposal to amend the Company’s amended and restated memorandum and articles of association (the “ Articles ”) to provide the Company with the right to extend the date by which the Company must consummate its initial business combination (the “ Extension ”), from March 15, 2024 to June 17, 2025 (the “ Extension Amendment Proposal ”). The Company’s shareholders also approved a proposal (the “ NTA Requirement Amendment Proposal ”) to amend the Articles of Association to delete: (i) the limitations that the Company shall not consummate a business combination (as defined in the Articles of Association) if it would cause the Company’s net tangible assets (“ NTAs” ) to be less than $5,000,001; and (ii) the limitations that the Company shall not redeem or repurchase its ordinary shares in an amount that would cause the Company’s NTAs to be less than $5,000,001 following such redemptions or repurchases, as applicable (the “ NTA Requirement”
AleAnna, Inc. shareholders approved Adjournment Proposal.
“Approval of Proposal 4 - Adjournment Proposal Votes For Votes Against Abstentions 5,795,220 218,219 111,369”
AleAnna, Inc. shareholders approved NTA Requirement Amendment Proposal.
“Approval of Proposal 3 - NTA Requirement Amendment Proposal Votes For Votes Against Abstentions 5,784,155 229,284 111,369”
AleAnna, Inc. shareholders approved Trust Amendment Proposal.
“Approval of Proposal 2 - Trust Amendment Proposal Votes For Votes Against Abstentions 5,893,439 231,364 5”
AleAnna, Inc. shareholders approved Extension Amendment Proposal.
“Approval of Proposal 1 - Extension Amendment Proposal Votes For Votes Against Abstentions 5,893,439 231,364 5”
AleAnna, Inc. amended Second Trust Amendment with Continental Share Transfer & Trust Company (effective 2024-03-15).
“On March 15, 2024, the shareholders of Swiftmerge Acquisition Corp. (the “ Company ”) at the reconvened extraordinary general meeting of the Company which had been adjourned from March 13, 2024 (the “ Meeting ”) approved an amendment (the “ Second Trust Amendment ”) of that certain investment management trust agreement, dated December 17, 2021, as amended on June 15, 2023 (the “ Trust Agreement ”), by and between the Company and Continental Share Transfer & Trust Company, a New York corporation, as trustee (“ Continental ”), to change the date on which Continental must commence liquidation of the trust account established in connection with the Company’s initial public offering (the “ Trust Account ”) to the earliest of (i) the Company’s completion of an initial business combination and (ii) June 17, 2025 (the “ Extension Date ”).”
AleAnna, Inc. shareholders approved Approval of adjournment of extraordinary general meeting at the 2024-03-13 meeting.
“The following is a tabulation of the votes with respect to the Adjournment Proposal, which was approved by the Company's shareholders: Approval of Adjournment Proposal Votes For Votes Against Abstentions 5,795,220 218,219 111,369”
AleAnna, Inc. terminated Merger Agreement and Mutual Termination Agreement with HDL Therapeutics, Inc., and IVCP Merger Sub, Inc. valued at Mutual termination of Merger Agreement; no termination fee. (effective 2024-02-14).
“On February 14, 2024, the Company, HDL and Merger Sub entered into a Mutual Termination Agreement (the “ Mutual Termination Agreement ”) pursuant to which they terminated the Merger Agreement by mutual agreement in accordance with Section 10.1(d) thereof, and each party, on behalf of itself and its agents, released, waived and forever discharged the other parties and their agents of and from any and all obligation or liability arising under the Merger Agreement.”
AleAnna, Inc. reported that prior financial statements should not be relied upon.
“As a result, management determined that it is appropriate to restate the Company’s previously issued audited financial statements for the year ended December 31, 2022, included in the Company’s previously filed Annual Report on Form 10-K with the Securities and Exchange Commission (the “Form 10-K”), and the unaudited financial statements for the three months ended March 31, 2023, included in the Company’s previously filed Quarterly Report on Form 10-Q with the Securities and Exchange Commission (the “Form 10-Q” and collectively with the Form 10-K and the financial statements included in the Form 10-K and the Form 10-Q, the “Non-Reliance Financial Statements”). The Company’s audit committee concluded that the Non-Reliance Financial Statements should no longer be relied upon, and that the Company will amend the Form 10-K and the Form 10-Q to include restatements of the Non-Reliance Financi”
AleAnna, Inc. entered into Merger Agreement with HDL Therapeutics, Inc. and IVCP Merger Sub, Inc. valued at $400,000,000 (effective 2023-08-11).
“On August 11, 2023, Swiftmerge entered into a Merger Agreement (the “ Merger Agreement ”) with HDL Therapeutics, Inc., a Delaware corporation (“ HDL ”), and IVCP Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Swiftmerge (“ Merger Sub ” and, together with Swiftmerge and HDL the “ Parties ”). Capitalized terms used in this Current Report on Form 8-K but not otherwise defined herein have the meanings given to them in the Merger Agreement. The Merger The Merger Agreement provides that, among other things and upon the terms and subject to the conditions thereof, the following transactions will occur (together with the other agreements and transactions contemplated by the Merger Agreement, the “ Business Combination ”): (i) at the closing of the transactions contemplated by the Merger Agreement (the “ Closing ”), upon the terms and subject to the conditions of the Merger Agreement, in accordance with the General Corporation Law of the State of Delaware, as a”
AleAnna, Inc. shareholders approved Adjournment Proposal.
“Approval of Proposal 4 - Adjournment Proposal Votes For Votes Against Abstentions 20,477,928 934,940 0”
AleAnna, Inc. shareholders approved Founder Share Amendment Proposal.
“Approval of Proposal 3 - Founder Share Amendment Proposal Votes For Votes Against Abstentions 20,480,457 932,411 0”
AleAnna, Inc. shareholders approved Trust Amendment Proposal.
“Approval of Proposal 2 - Trust Amendment Proposal Votes For Votes Against Abstentions 20,480,457 932,411 0”
AleAnna, Inc. shareholders approved Extension Amendment Proposal.
“Approval of Proposal 1 - Extension Amendment Proposal Votes For Votes Against Abstentions 20,480,457 932,411 0”
AleAnna, Inc. entered into Voting and Non-Redemption Agreement with one or more unaffiliated third party or parties (effective 2023-06-06).
“On June 6, 2023, the Company entered into voting and non-redemption agreements (each, a “Voting and Non-Redemption Agreement”) with one or more unaffiliated third party or parties (the “Shareholders”)”
AleAnna, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
“April 19, 2023, Swiftmerge Acquisition Corp. (the “Company”) received a letter (the “Non-Compliance Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to have timely filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “2022 10-K”). The Non-Compliance Letter provides the Company with 60 calendar days, or until June 20, 2023, to submit to Nasdaq a plan to regain compliance in accordance with Nasdaq’s listing require”
Sarah Boatman was appointed as Director at AleAnna, Inc..
“On December 14, 2021, General (Ret.) Wesley K. Clark, Brett Conrad, Dr. Leonard Makowka, Dr. Courtney Lyder and Sarah Boatman were appointed as members of the board of directors of the Company”
Courtney Lyder was appointed as Director at AleAnna, Inc..
“On December 14, 2021, General (Ret.) Wesley K. Clark, Brett Conrad, Dr. Leonard Makowka, Dr. Courtney Lyder and Sarah Boatman were appointed as members of the board of directors of the Company”
Leonard Makowka was appointed as Director at AleAnna, Inc..
“On December 14, 2021, General (Ret.) Wesley K. Clark, Brett Conrad, Dr. Leonard Makowka, Dr. Courtney Lyder and Sarah Boatman were appointed as members of the board of directors of the Company”
Brett Conrad was appointed as Director at AleAnna, Inc..
“On December 14, 2021, General (Ret.) Wesley K. Clark, Brett Conrad, Dr. Leonard Makowka, Dr. Courtney Lyder and Sarah Boatman were appointed as members of the board of directors of the Company”
Wesley K. Clark was appointed as Director at AleAnna, Inc..
“On December 14, 2021, General (Ret.) Wesley K. Clark, Brett Conrad, Dr. Leonard Makowka, Dr. Courtney Lyder and Sarah Boatman were appointed as members of the board of directors of the Company”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.